Primary cutaneous T-cell lymphoma localized to the lower leg: A distinct, locally aggressive cutaneous T-cell lymphoma

Archives of Dermatology

Volumn 145, Issue 6, 2009, Pages 677-682

  Poligone, Brian ^a   Wilson, Lynn D ^b   Subtil, Antonio ^b   Heald, Peter ^b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGATOLIMOD; BEXAROTENE; CHLORMETHINE; CLOBETASOL PROPIONATE; DENILEUKIN DIFTITOX; DOXORUBICIN;

AGED; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL ASSESSMENT; CUTANEOUS T CELL LYMPHOMA; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LEG; MALE; PRIORITY JOURNAL; SKIN BIOPSY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BIOPSY, NEEDLE; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LOWER EXTREMITY; LYMPHOMA, T-CELL, CUTANEOUS; MALE; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SKIN NEOPLASMS; SURVIVAL RATE; TREATMENT FAILURE;

EID: 67449161806     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.84     Document Type: Article

References (17)

1. Lutzner M, Edelson R, Schein P, Green I, Kirkpatrick C, Ahmed A. Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders. Ann Intern Med. 1975;83(4):534-552.
2. Trautinger F, Knobler R, Willemze R, et al. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome. Eur J Cancer. 2006;42(8):1014-1030.
3. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768-3785.
4. Hoque SR, Child FJ, Whittaker SJ, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patients. Br J Dermatol. 2003;148(3):516-525.
5. Toro JR, Liewehr DJ, Pabby N, et al. Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma. Blood. 2003;101(9):3407-3412.
6. Haycox CL, Back AL, Raugi GJ, Piepkorn M. Subcutaneous T-cell lymphoma treated with systemic chemotherapy, autologous stem cell support, and limb amputation. J Am Acad Dermatol. 1997;37(5, pt 2):832-835.
7. Grange F, Beylot-Barry M, Courville P, et al. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases. Arch Dermatol. 2007;143(9):1144-1150.
8. Petrella T, Maubec E, Cornillet-Lefebvre P, et al. Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma? Am J Surg Pathol. 2007;31(12):1887-1892.
9. Bekkenk MW, Vermeer MH, Jansen PM, et al. Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients. Blood. 2003;102(6):2213-2219.
10. Haghighi B, Smoller BR, LeBoit PE, Warnke RA, Sander CA, Kohler S. Pagetoid reticulosis (Woringer-Kolopp disease): an immunophenotypic, molecular, and clinicopathologic study. Mod Pathol. 2000;13(5):502-510.
11. Narasimhan P, Arora A, Hitti I, Glasberg S, Kanzer B. Rapidly progressive fatal cutaneous T cell lymphoma with a trauma-related presentation. Cutis. 2000;66(3):195-198.
12. Yagi H, Ogai M, Izumi T, et al. Cutaneous T-cell lymphoma with massive co-infiltration of polyclonal B cells. Br J Dermatol. 1994;130(2):226-230.
13. Zoi-Toli O, Meijer CJ, Oudejans JJ, de Vries E, van Beek P, Willemze R. Expression of Fas and Fas ligand in cutaneous B-cell lymphomas. J Pathol. 1999;189(4):533-538.
14. Hallel-Halevy D, Yerushalmi J, Grunwald MH, Avinoach I, Halevy S. Stewart- Treves syndrome in a patient with elephantiasis. J Am Acad Dermatol. 1999;41(2, pt 2):349-350.
15. Masood R, Cai J, Zheng T, Smith DL, Naidu Y, Gill PS. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci U S A. 1997;94(3):979-984.
16. Sordillo EM, Sordillo PP, Hajdu SI, Good RA. Lymphangiosarcoma after filarial infection. J Dermatol Surg Oncol. 1981;7(3):235-239.
17. Bunnapradist S, Vo A, Toyoda M, et al. Posttransplantation lymphoproliferative disorder presenting as a unilateral leg mass 10 years after kidney transplantation. Transplantation. 2002;74(11):1648-1651.